BioCentury | Nov 10, 2006
Financial News

Solstice raises $85 million

...the series B round, which included participation by existing investors Thomas, McNerney; Investor Growth Capital; Morgan Stanley Venture Partners...
BioCentury | Oct 22, 2001
Finance

Ebb & Flow

...Israeli CNS play D-Pharm. Other investors included many in Care Capital's network of investors, including Morgan Stanley Venture Partners...
BioCentury | Oct 16, 2001
Financial News

D-Pharm raises $30 million

...diseases, raised $30 million in a private round led by Care Capital. Other investors included; Morgan Stanley Venture Partners...
BioCentury | Jun 18, 2001
Finance

Ebb & Flow

...work, participating in a $31.4 million financing for NitroMed . Other investors include Rho Ventures; Morgan Stanley Venture Partners...
BioCentury | Jun 18, 2001
Finance

Ebb & Flow

...work, participating in a $31.4 million financing for NitroMed . Other investors include Rho Ventures; Morgan Stanley Venture Partners...
BioCentury | Jun 14, 2001
Financial News

NitroMed raises $31.4 million

...BiDil NDA (see BioCentury, March 12). Investors in the financing included Rho Ventures; Care Capital; Morgan Stanley Venture Partners...
BioCentury | Sep 8, 1998
Company News

Medicines Co. board of directors update

...Financing, B11) The Medicines Co., Cambridge, Mass. Business: Cardiovascular, Neurological Appointed: Fazle Husain, principal at Morgan Stanley Venture Partners WIR...
Items per page:
1 - 7 of 7
BioCentury | Nov 10, 2006
Financial News

Solstice raises $85 million

...the series B round, which included participation by existing investors Thomas, McNerney; Investor Growth Capital; Morgan Stanley Venture Partners...
BioCentury | Oct 22, 2001
Finance

Ebb & Flow

...Israeli CNS play D-Pharm. Other investors included many in Care Capital's network of investors, including Morgan Stanley Venture Partners...
BioCentury | Oct 16, 2001
Financial News

D-Pharm raises $30 million

...diseases, raised $30 million in a private round led by Care Capital. Other investors included; Morgan Stanley Venture Partners...
BioCentury | Jun 18, 2001
Finance

Ebb & Flow

...work, participating in a $31.4 million financing for NitroMed . Other investors include Rho Ventures; Morgan Stanley Venture Partners...
BioCentury | Jun 18, 2001
Finance

Ebb & Flow

...work, participating in a $31.4 million financing for NitroMed . Other investors include Rho Ventures; Morgan Stanley Venture Partners...
BioCentury | Jun 14, 2001
Financial News

NitroMed raises $31.4 million

...BiDil NDA (see BioCentury, March 12). Investors in the financing included Rho Ventures; Care Capital; Morgan Stanley Venture Partners...
BioCentury | Sep 8, 1998
Company News

Medicines Co. board of directors update

...Financing, B11) The Medicines Co., Cambridge, Mass. Business: Cardiovascular, Neurological Appointed: Fazle Husain, principal at Morgan Stanley Venture Partners WIR...
Items per page:
1 - 7 of 7